Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Depreciation and Depletion: 2019-2022

Historic Depreciation and Depletion for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Dec 2022 value amounting to $600,000.

  • Phathom Pharmaceuticals' Depreciation and Depletion fell 50.00% to $100,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $400,000, marking a year-over-year change of. This contributed to the annual value of $600,000 for FY2022, which is 20.00% up from last year.
  • Phathom Pharmaceuticals' Depreciation and Depletion amounted to $600,000 in FY2022, which was up 20.00% from $500,000 recorded in FY2021.
  • In the past 5 years, Phathom Pharmaceuticals' Depreciation and Depletion registered a high of $600,000 during FY2022, and its lowest value of $8,000 during FY2019.
  • In the last 3 years, Phathom Pharmaceuticals' Depreciation and Depletion had a median value of $500,000 in 2021 and averaged $466,667.
  • Data for Phathom Pharmaceuticals' Depreciation and Depletion shows a peak YoY surged of 3,650.00% (in 2020) over the last 5 years.
  • Over the past 4 years, Phathom Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $8,000 in 2019, then surged by 3,650.00% to $300,000 in 2020, then skyrocketed by 66.67% to $500,000 in 2021, then climbed by 20.00% to $600,000 in 2022.